Figure S1 (related to Figure 1 ). Endogenous ID complex is modified in response to DNA damage by the small ubiquitin-like modifiers SUMO1 and SUMO2. A. Current model of replication-dependent ICL repair (Knipscheer et al., 2009; Long et al., 2011; Raschle et al., 2008; Zhang and Walter, 2014) . B. HeLa/FLAG-SUMO1 cells were treated with doxycycline (DOX) for 48 h to induce the expression of FLAG-SUMO1. Cells were subjected to mitomycin C (MMC) (1 μM) or hydroxyurea (HU) (2 mM) treatment for 24 h and protein extracts were analyzed by immunoblotting with the indicated antibodies. WCE, whole cell extracts. C. Same as (B) except with HeLa/FLAG-SUMO2 cells. D. Stable HeLa cell lines expressing wild type FLAG-SUMO2 were treated with doxycycline (DOX) for 24 h to induce FLAG-SUMO2 expression. Cells were then lysed under denaturing conditions, subjected to FLAG immunoprecipitation and then analysed by immunoblotting using the indicated antibodies. WCE, whole-cell extract; IP, immunoprecipitates. MCM6 is used as a loading control. Left, example of Western blot data, showing SUMO-modified forms of FANCI in the whole cell extract and after immunoprecipitation of the SUMO1. Right, same data but after cropping the important bands. E. HeLa/FLAG-SUMO2 cells were exposed to various genotoxic stresses and processed as in (D). F. HeLa/FLAG-SUMO1 cells were treated with HU (2 mM) for various durations before being processed as in (D). G. Stable HeLa cell lines expressing wild type (WT) or conjugationdeficient (ΔGG) FLAG-SUMO1 were transfected or not with FANCI siRNA and treated with doxycycline (DOX) for 24 h to induce FLAG-SUMO2 expression. Cells were then subjected to MMC treatment for an additional 24 h and collected. SUMOylation of FANCI and FANCD2 was analysed as in (D). H. Same as in (G), using FANCD2 siRNA. I. HeLa/FLAG-SUMO1 cells were biochemically fractionated, diluted in denaturing buffer before immunopurification and immunoblotting with the indicated antibodies. A. U2OS cells were treated with HU (2 mM) for 2 h, pre-extracted in situ with detergent, fixed and then immunostained with FANCD2 and RPA2 antibodies together with DAPI to stain nuclear DNA content. QIBC can be used to discriminate RPA that is dynamically loaded on ssDNA produced by HU-induced fork stalling, compare left and right (Toledo et al., 2013) . B. As in (A) except the mean FANCD2 intensity is plotted against mean RPA2 intensity. Previous assessment of S-phase cells in (A) allows discrimination of S-phase chromatin loading of FANCD2 (red). C. As in (B) except total FANCD2 intensity is plotted against mean RPA2
intensity. Note that FANCD2 exists in three cellular populations after isolation of chromatin bound proteins using in situ pre-extraction: 1. low RPA, low FANCD2 (G1-phase); 2. low RPA, high FANCD2 (G2-phase telomere-associated structures (Fan et al., 2009 ); 3. intermediate-tohigh FANCD2, high RPA (S-phase). FANCI exhibits exactly the same dynamics (data not shown). D. Examples of images obtained from the high-content microscope used to generate data in A-C, showing predominantly G1 and S-phase cells. E. As in (D), but showing mainly S and G2 cells. F. Assessment of siSENP6 Smartpool depletion efficiency by immunoblotting. G. U2OS were transfected with HA-Strep-SENP6 CI , subjected to laser microirradiation, pre-extracted or not, fixed and immunostained with the indicated antibodies. Scale bar, 10 μm. Figure S4 (related to Figure 4 ).
RNF4-mediated polyubiquitylation of the ID complex.
A. RNF4 mutants used in this study. The hydrophobic residues of the Nterminal SIM region were mutated to alanines to give rise to the *SIM mutant. Two cysteines in the C-terminal RING domain were mutated to serine, to create the *RING mutant. B. Immunoblot assessment of RNF4 siRNAs used in this study. C. U2OS cells were transfected with control (CTRL) or RNF4 siRNA then transfected with RNF4 or RNF4 siRNA-resistant (RNF4 siR ) expression constructs, before whole cell extracts were assessed by immunoblotting to determine efficiency of RNF4 siR resistance to RNF4 siRNAs. D. Generation of U2OS stable cell lines expressing similar levels of mCherry-RNF4 siR wild type and mutant alleles, as assessed by immunoblotting with the indicated antibodies. E. Schematic showing the principle of the multicolor competition assay (MCA) (Smogorzewska et al., 2007) used in Fig 4A. F. The U2OS/mCherry-RNF4 siR *RING mutant was transfected with RNF4 siRNA, treated with MMC (0.3 μM) for 24 h, pre-extracted, fixed and immunostained with FANCD2 antibody. Scale bar, 10 μm. G. U2OS cells were transfected with GFP-RNF4 siR constructs, treated with MMC (1 μM) for 4 h, before immunoprecipitation with GFP-Trap beads followed by immunoblotting with the indicated antibodies. H. U2OS/HA-Strep-ubiquitin cells were transfected with control or RNF4 siRNA, treated with HU (2 mM) for 24 h and in the last 4 h were treated with the proteasome inhibitor MG132 (10 μM), before cells were lysed under denaturing conditions, immunopurified using Strep-Tactin Sepharose and analysed by immunoblotting with indicated antibodies. I. U2OS cells were transfected with wild type HA-Strep-ubiquitin (WT), or two derivatives containing only one available lysine, K48 (K48 only ) or K63 (K63 only ), exposed to HU (2 mM) for 24 h and in the last 6 h were treated with the proteasome inhibitor MG132 (10 μM), before cells were lysed under denaturing conditions, immunopurified using Strep-Tactin Sepharose and analysed by immunoblotting with the indicated antibodies. J. U2OS/FANCI cells were transfected with wild type HA-Strep-ubiquitin (WT), or two derivatives containing K48R or K63R mutations, treated with HU (2 mM) for 24 h and in the last 4 h were treated with the proteasome inhibitor MG132. Ubiquitin-associated FANCI was then analysed after HA purification and immunoblotting with antibody against endogenous FANCI. K. HeLa/FLAG-SUMO2 cells were transfected with control or RNF4 siRNA, induced for SUMO expression by DOX addition, then treated with HU (2 mM) for 24 h and in the last 6 h treated with MG132, then lysed under denaturing conditions, immunopurified using FLAG beads and analysed by immunoblotting using the indicated antibodies. L. Coomassie-stained gels of recombinant His-Strep-HA-RNF4 and UBCH5b proteins used in this study. Figure S5 (related to Figure 5) . DVC1 is the specific p97 adaptor that promotes extraction of the ID complex in a ubiquitin-dependent manner.
A. U2OS cells were co-transfected with FLAG-DVC1 and p97-Myc wild type (WT) or ATPase-dead E578Q (EQ), treated with HU (2 mM) for 24 h and then pre-extracted, fixed and immunostained with the indicated antibodies. Scale bar, 10 μm. B. U2OS cells were co-transfected with GFP-DVC1 wild type (WT), *SHP or *UBZ together and p97-Myc, treated with MMC (0.3 μM) for 24 h and then pre-extracted or not, fixed and immunostained with the indicated antibodies. Note that the GFP-DVC1 ubiquitin-binding deficient *UBZ mutant is completely solubilised followed pre-extraction, indicating that it is not stably retained on chromatin in response to replication stress (unextracted panel). Scale bar, 10 μm. C. U2OS/GFP-DVC1 cells were transfected with CTRL, FANCA or FANCD2 siRNA, treated with either HU (2 mM) or MMC (0.3 μM) for 24 h and then fixed. Scale bar, 10 μm. D. U2OS cells were co-transfected with FLAG-NPL4, FLAG-UFD1 or FLAG-p47 together with p97-Myc, treated with MMC (0.3 μM) for 24 h and then fixed and immunostained with the indicated antibodies. Note that each of these p97 adaptor proteins was unable to promote extraction of the ID complex after ICL formation. Furthermore, none were resistant to an in situ pre-extraction step (data not shown), indicating that they are not stably recruited to stalled replication forks. High (HI) and low (LO) expressing cells were included for comparison. Scale bar, 10 μm. E. Immunoblot analysis of HeLa cells used for clonogenic assays in Fig  5E. B A. Location and protein sequence alignment of potential SUMO sites in FANCI. B. FANCI SUMO site K-to-R expression constructs used in this study. The HA-FANCI *SUMO mutant contains all six K-to-R substitutions. C. U2OS cells were transfected with HA-FANCI wild type (WT) or SUMO site mutants and where indicated His-FLAG-SUMO2, subjected to HU treatment (2 mM) and 24 h later SUMO conjugates were purified under denaturing conditions using Ni 2+ agarose. SUMO-modified FANCI was analysed by immunoblotting with HA antibody. *, denotes unmodified FANCI in immunoprecipitate. D. FANCI SUMO sites in the context of the previously described FANCD2/FANCI crystal structure (Joo et al., 2011) (PDB: 3S4W). Electrostatic surface and images were created using Pymol. Notably, the K715 residue is followed by a string of conserved negatively charged amino acids and an SQ phosphorylation site, which further classifies the K715 site as a negatively charged amino acid dependent SUMOylation motif (NDSM) (Yang et al., 2006) . The negatively charged amino acids within this specialised SUMO motif promotes interaction with a basic patch on the SUMO E2 UBC9, thus targeting UBC9 to substrates to promote their SUMOylation (Mohideen et al., 2009) . Viewed within the context of the ID complex crystal structure, the FANCI K4, K638, K715, K1248 and K1288 are all surface accessible for the SUMOylation machinery. In contrast, the K646 residue is buried within the ID complex and would require restructuring of the complex in order to undergo SUMOylation. E. U2OS/HA-FANCI WT or *SUMO cells transfected with FANCI siRNA against the 3'-UTR were treated with HU (2 mM) for 24 h and lysed under denaturing conditions before immunoprecipitation with anti-FANCD2 antibody or pre-immune serum (IgG). Bound material was analysed by immunoblotting with the indicated antibodies. Figure S7 (related to Figure 7) . HA-FANCI WT phenocopies endogenous FANCI. U2OS/HA-FANCI WT cells were depleted of endogenous FANCI together with FANCD2, SENP6, RNF4 or DVC1 and processed for QIBC. Results of a representative experiment are shown.
